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Abstract
Background: Comparability of 25-hydroxyvitamin D (25(OH)D) measurements is hampered by method-related
differences in measurement values. International standardization of laboratory assays has been suggested to solve
this problem.
Methods: As part of the European Commission–funded project ‘Food-based solutions for optimal vitamin D
nutrition and health through the life cycle’ (ODIN), original measurements of serum 25(OH)D of three German
national health surveys conducted between 1998 and 2011 have been standardized retrospectively. In these
representative population-based samples including persons aged between 1 and 79 years, the original 25(OH)D
values were compared with those after standardization. Mean values and prevalences of vitamin D deficiency,
insufficiency, and sufficiency (25(OH)D levels < 30, 30- < 50, and > =50 nmol/l, respectively) were calculated by
sex and age groups based on original and standardized 25(OH)D data.
Results: In comparison to the original 25(OH)D levels, the standardized levels showed higher means overall and in
age- and sex-specific analyses. After standardization, the prevalence of vitamin D deficiency was lower in all surveys
while the prevalence of vitamin D sufficiency was higher. Nevertheless, even after standardization ~ 15% of adults
and 12.5% of children had serum 25(OH)D levels < 30 nmol/l. Thus, the proportion of deficient vitamin D levels in
the German population is still considerable.
Conclusions: The use of standardization of 25(OH)D levels has a substantial impact on estimates of the vitamin D
status in Germany. Since clinical diagnostic, therapeutic and public health decision-making require valid and
comparable data, standardization and calibration of commercial, clinical and research laboratory assays for 25(OH)D
measurement should become common practice. Until then, researchers, health practitioners and policy makers
should be aware of the peculiarities of the measurement methods when comparing and interpreting 25(OH)D levels.
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Background
In the last decade, there has been an explosion of research
related to, as well as major public interest in, the health
impacts of vitamin D. A long-recognized endocrine func-
tion of vitamin D is the regulation of calcium and phos-
phorus metabolism. As vitamin D plays an important role
in the mineralization of bone, it is not surprising that
long-term deficiency can lead to metabolic bone disorders,
including rickets in children and osteomalacia or osteo-
porosis in adults [1–5]. In addition, there have been nu-
merous reports of associations between vitamin D status
with a wide spectrum of health conditions and diseases
beyond bone, including diabetes mellitus, cardiovascular
diseases and different types of cancer [2, 6, 7], even though
much about the causal pathway(s) involved is still unclear.
To assess vitamin D status, 25(OH)D measured in
serum or plasma is an accepted indicator and widely used
in both epidemiological research and clinical practice [8].
However, for the measurement of 25(OH)D, different as-
says are available including competitive binding-protein
assays, immunoassays (e.g. chemiluminescent immuno-
assay [CLIA]), high performance liquid chromatography
(HPLC), and liquid chromatography-tandem mass spec-
trometry (LC-MS/MS), which is currently considered to
be more accurate and precise [9, 10]. Several studies have
shown that different laboratory procedures can yield
markedly divergent results for the measured 25(OH)D
values due to inter- and between-assay variability as well
as inter- and between-laboratory discrepancies [11–14].
Those widespread, method-related differences in results of
total 25(OH)D hamper comparability of 25(OH)D mea-
surements and progress in the field of vitamin D and
health. In particular, they confound the comparison of
vitamin D status between countries and World regions as
well as assessment of temporal changes. Accordingly,
there has been efforts in recent times to standardize the
measurement of circulating 25(OH)D in both clinical and
research laboratories [15, 16].
The Vitamin D Standardization Program (VDSP) orga-
nized by the Office of Dietary Supplements of the National
Institutes of Health, USA, was established in November
2010 to address the issue [11, 15, 16]. The main goal of the
VDSP is the promotion of a standardized 25(OH)D meas-
urement which is accurate and comparable between differ-
ent time points, laboratories, and laboratory procedures by
calibration of commercial, clinical and research laboratory
25(OH)D assays. A principal objective is the standardization
of 25(OH)D measurement in national health and nutrition
surveys by applying VDSP standardization protocols [11].
The VDSP protocols for standardization of serum 25(OH)D
data from past surveys have been applied to national sur-
veys in Canada [17], the US [18] and a number of nationally
or regionally representative samples in Europe [16, 19]. As
part of the European standardization exercises, two German
national health surveys (‘German Health Interview and
Examination Survey for Adults’, DEGS1, and ‘German
Health Interview and Examination Survey for Children and
Adolescents’, KiGGS) [20–22] were included in the wider
collection of 14 European population studies (n = 55,844)
[23]. However, this exercise only reported data on serum
25(OH)D on the entire population. While these analyses
permit the estimation of standardized 25(OH)D levels and
propensities of vitamin D deficiency in the contributing
countries, they, by design, do not provide a deeper insight
into potential differences among age-groups within the
wider population groups.
In the present work, we used this opportunity to provide
a more in-depth analysis of vitamin D status and to
compare prevalences of vitamin D deficiency, insufficiency
and sufficiency in the German population based on the
original measurements with those after standardization
from the two surveys but also stratified by age-groups. In
addition, we used standardized serum 25(OH)D data from
an older German national health survey of adults (‘German
National Health Interview and Examination Survey 1998’,
GNHIES98), not previously reported, to undertake a
comparison of data from two cross-sectional surveys in
Germany over a ten year period. This new data is of special
interest for clinical practice and public health policy.
Methods
Study design and subjects
GNHIES98, DEGS1, and KiGGS were conducted by the
Robert Koch Institute, Berlin. The design and methods
have been described in detail elsewhere [24–30]. In brief,
the sample design of each survey included two steps. First,
geographical sample points were chosen randomly in
proportion to the population size of the federal states and
communities. In total, 120 sample points for GNHIES98,
180 sample points for DEGS1 and 160 sample points for
KiGGS were included. Second, within each sample point
persons were randomly selected stratified by age from
local population registries.
GNHIES98
GNHIES98 was conducted from October 1997 to March
1999. It included a nationwide representative
population-based sample of adults aged 18–79 years. The
response rate was 61.4% [24, 25]. Overall, 7124 persons
participated in GNHIES98. Of these, 4030 persons (2267
women, 1763 men) took part in the German Nutrition
Survey 1998, a module of GNHIES98 [26]. The present
analysis is restricted to participants of this substudy with
valid 25(OH)D data (2211 women; 1706 men).
DEGS1
DEGS1 was conducted from November 2008 to De-
cember 2011. It included a nationwide representative
Rabenberg et al. BMC Public Health  (2018) 18:845 Page 2 of 14
population-based sample of adults aged 18–79 years.
DEGS1 used a mixed design including both persons
who already participated in the GNHIES98 (response
rate 62%) and participants who were newly recruited
by two-stage stratified random sampling (response
rate 42%) [27]. Overall, 7987 adults participated in
DEGS1 including 6995 persons with available serum
25(OH)D levels (3635 women; 3360 men).
KiGGS
KiGGS was conducted from May 2003 to May 2006 and
included a nationwide representative population-based
sample of children and adolescents aged 0–17 years. A
total of 17,641 children and adolescents participated in
KiGGS (response rate 66.6%) [30]. In the present study,
we had to exclude 935 children < 1 year of age from
whom no blood samples were obtained, 2319 children
whose parents declined blood draw and 4366 partici-
pants whose blood was measured during the first study
year before a change in laboratory method. Thus, in
KiGGS we examined 10,015 participants with available
serum 25(OH)D levels (4907 girls; 5108 boys).
Data collection and laboratory measurement of serum
25-hydroxyvitamin D
All surveys comprised, among other survey instruments,
measurements in blood samples. Venous blood samples
were drawn at study centers and immediately processed
and separated. Serum samples were aliquoted, stored at
− 40 °C and then transported and analyzed at the central
epidemiology laboratory unit at the Robert Koch Insti-
tute. Measurement of serum 25(OH)D was carried out
using a chemiluminescent immunoassay (CLIA, LI-
AISON® 25 OH Vitamin D TOTAL Assay), one of the
most commonly used methods in clinical and research
laboratories. Details on analyses have been described
elsewhere [20–22].
Application of VDSP standardization protocol to existing
25(OH)D levels
As part of the European Commission–funded project
‘Food-based solutions for optimal vitamin D nutrition and
health through the life cycle’ (ODIN), serum 25(OH)D
levels from GNHIES, DEGS1 and KiGGS were retrospect-
ively standardized by applying a VDSP protocol for
standardization of existing serum 25(OH)D data [23]. The
protocol has been described in detail elsewhere [11]. In
brief, this included the 25(OH)D re-analysis of a subset
(GNHIES98 n = 171; DEGS1 n = 163; KiGGS n = 160) of
bio-banked serum samples (stored at − 40 °C) which were
identified by dividing the range of the previous
CLIA-based serum 25(OH)D measurements from the en-
tire survey sample into quartiles, with each quartile being
sampled according to a uniform distribution [19, 31]. The
bio-banked serum samples from each of the studies were
analyzed separately by using University College Cork’s
LC-MS/MS assay, which has been certified by the Centers
for Disease Control and Prevention (CDC) as being trace-
able to the Reference Measurement Procedures (RMP) of
the National Institute for Standards and Technology
(NIST), Ghent University, and CDC [9, 32–35].
Statistical analyses
Analyses were performed with SPSS statistical software
(version 20.0; SPSS, Chicago, IL, USA), SAS (version 9.4;
SAS Institute, Cary, NC, USA) and STATA (version 12;
StataCorp LP, College Station, TX, USA). Simple linear,
piecewise linear and Deming regression models were used
to examine the best-fit relation between serum 25(OH)D
levels derived from CLIA and LC-MS/MS, which is
described in detail elsewhere [16, 23]. The resulting re-
gression equation which provided the best fit was applied
to the entire data set from each study to create standard-
ized data sets. Mean values and prevalence estimates of
vitamin D deficiency, insufficiency and sufficiency (defined
as serum 25(OH)D levels < 30 nmol/l, 30- < 50 nmol/l
and > =50 nmol/l, respectively [3]) were calculated by sex
and age groups based on original and standardized
25(OH)D data. For these analyses, a weighting factor was
applied which adjusts for different sampling probabilities
within the design strata and corrects deviations in the
sample from the German population structure (at the time
of each particular survey), taking into account age, sex,
region, nationality, community type and education. The
relation between the original and re-analyzed serum
25(OH)D values was analyzed using regression models
(ordinary least squares, Deming, and piecewise), as
described in detail elsewhere [16–19, 23].
Results
Characteristics of the three study populations, stratified
by sex and age group are shown in Table 1. The
weighted percentage for sex and age groups reflect the
distribution in the German population at time of survey.
In GNHIES98, overall, 51.6% of the study population
were women and 48.4% were men. In DEGS1, 50.2% of
the participants were women, 49.8% were men. In
KiGGS, 48.6% were girls and 51.4% were boys.
The coefficients of the regression equations describing
the relation between 25(OH)D in the VDSP identified
subsets of serum samples from GNHIES98, DEGS1 and
KiGGS, originally measured by CLIA and re-analyzed by
LC-MS/MS, is shown in Table 2. For all three study popu-
lations, piecewise regression models provided the best fit
(Figs. 1, 2, and 3) and the resulting regression equations
were applied to the entire data set from each of the
respective studies. The change points for the piecewise
regression lines were about 73 for GNHIES98, 122 for
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DEGS1 and 60.5 for KiGGS samples, respectively (Table
2). For the GNHIES98 and KIGGS samples the lines are
still rising after these points but less steeper. For DEGS1 it
becomes almost flat.
The weighted relative frequencies for serum 25(OH)D
as measured by using the CLIA and after standardization
with the regression equations derived from the compari-
son with LC–MS/MS are shown in Figs. 4, 5, and 6. The
distinct peaks are due to the underlying piecewise re-
gression models. In each survey, standardization shifted
the distribution of 25(OH)D to the right.
Moreover, in each survey, mean serum 25(OH)D levels
based on the original measurements were lower in com-
parison to measurements after standardization across all
age groups in men and women (Tables 3 and 4) and in girls
and boys (Table 5). In GNHIES98, the standardized mean
serum 25(OH)D level was 62.0 nmol/l (58.9–65.1) in
women and 60.9 nmol/l (57.1–64.7) in men (Table 3),
whereas the standardized mean serum 25(OH)D level in
DEGS1 was 49.7 nmol/l (48.2–51.3) among women and
49.3 nmol/l (47.4–51.2) among men (Table 4). In KiGGS,
the standardized mean serum 25(OH)D level was
53.2 nmol/l (51.1–55.3) in girls and 53.7 nmol/l (51.5–56.0)
in boys (Table 5).
Following standardization of serum 25(OH)D data, the
estimated prevalence of vitamin D deficiency (i.e. serum
25(OH)D < 30 nmol/l) in the population was lowered by
half in both DEGS1 (from 30.2 to 15.2%) and KiGGS
(from 27.0 to 12.5%) and by one third in GNHIES98
(from 23.7 to 15.5%) (Tables 3, 4, and 5 and Fig. 7). In
contrast, the estimated prevalence of vitamin D suffi-
ciency (i.e. serum 25(OH)D > =50 nmol/l) increased after
standardization in each of the surveys (Tables 3, 4, and 5
and Fig. 7).
The effects of standardization are somewhat different
for specific sex and age groups. Subgroup analyses also
clearly show differences between analyses of originally
measured and standardized values, especially in the low
and high end of the distribution (Tables 3, 4, and 5).
This is due to the fact that the CLIA used in GNHIES98
and KiGGS underestimated serum 25(OH)D in the low
end of the distribution and overestimated it in the high
end whereas the CLIA used in DEGS1, however, under-
estimated serum 25(OH)D in both the low and high end
of the distribution (Table 6).
In GNHIES98, the proportion of serum 25(OH)D
< 30 nmol/l was higher in women aged 18 to 29 than in
men of the same age (18.7% vs. 11.9%), while the
Table 1 Characteristics of the study populations of GNHIES98, DEGS1 and KiGGSa,b
GNHIES98 DEGS1 KiGGS
Women Men Total Women Men Total Girls Boys Total
n % n % n % n % n % n % n % n % n %
Age group (in years)
Adults Children
18–29 1–2 440 17.1 328 18.8 768 17.9 534 18.4 513 19.2 1047 18.8 390 10.1 395 10.1 785 10.1
30–39 3–6 539 20.9 399 22.8 938 21.8 426 14.4 403 14.9 829 14.6 1050 21.9 1079 21.9 2129 21.9
40–49 7–10 425 17.5 301 19.0 726 18.2 683 20.9 593 22.1 1276 21.5 1274 22.7 1340 22.5 2614 22.6
50–59 11–13 376 16.8 312 17.5 688 17.1 744 18.3 636 18.4 1380 18.3 981 18.1 1047 17.9 2028 18.0
60–69 14–17 287 15.3 259 14.7 546 15.0 709 14.4 668 13.8 1377 14.1 1212 27.3 1247 27.5 2459 27.4
70–79 – 144 12.3 107 7.3 251 9.9 539 13.6 547 11.6 1086 12.6 – – – – – –
Total 2211 51.6 1706 48.4 3917 100.0 3635 50.2 3360 49.8 6995 100.0 4907 48.6 5108 51.4 10,015 100.0
a Results are weighted, except the number of cases
b Rounding may result in minor variations in totals and percentages
Table 2 Coefficients of the piecewise regression model between 25(OH)D levels derived from CLIA and LC-MS/MS
If Rvala ≤ value If Rval ≥ value
Study Value Intercept 1 X1b Value Intercept 2 X2b R2
GNHIES98 73.2698 −0.2256 1.2197 73.2698 49.0336 0.5474 0.94
DEGS1 121.9968 14.5310 0.7715 121.9968 102.1919 0.0530 0.79
KiGGS 60.5211 9.4005 1.0225 60.5211 52.4099 0.3119 0.81
25(OH)D Serum 25-hydroxyvitamin D, CLIA Chemiluminescent immunoassay, LC-MS/MS Liquid chromatography-tandem mass spectrometry, GNHIES98 German
National Health Interview and Examination Survey 1998, DEGS1 German Health Interview and Examination Survey for Adults, KiGGS German Health Interview and
Examination Survey for Children and Adolescents
a In piecewise regression, the independent variable is partitioned into intervals and a separate line segment is fit to each interval (Rval = change point in serum
25(OH)D concentration) [23]
b X1, X2 = slopes of the regression lines
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proportion of serum 25(OH)D > 50 nmol/l was higher
in men aged 18 to 29 years than in women of the same
age (68.3% vs. 57.6%) (Table 3). However, men aged 60
to 69 years and 70 to 79 years had proportions of
serum levels of 25(OH)D < 30 nmol/l which were twice
as high as those of women of the same age (60 to
69 years: 16.9% vs. 7.3%; 70 to 79 years: 30.2% vs.
18.5%). At the other side, the proportion of serum
25(OH)D levels > 50 nmol/l was much higher in
women aged 60 to 69 years and 70 to 79 years than in
men (60 to 69 years: 68.8% vs. 49.2%; 70 to 79 years:
49.9% vs. 36.9%).
In DEGS1, the proportion of standardized serum
25(OH)D values < 30 nmol/l was relatively stable across
all age groups and sexes, ranging from 13.3 to 19.4%
(Table 4). Only participants aged 60 to 69 showed mark-
edly lower proportions with 9.8% among women and 9.9%
among men. Women aged 30 to 39 years had a higher
proportion of serum 25(OH)D values > 50 nmol/l than
men of the same age (48.3% vs. 38.4%), while the opposite
was true for the two highest age groups (60 to 69 years:
52.1% vs. 41.7%; 70 to 79 years: 41.5% vs. 33.0%).
In KiGGS, the prevalence of vitamin D deficiency
increased from young children to teenagers (Table 5). In
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Fig. 1 Calibration study results used to standardize serum samples from GNHIES98. 25(OH)D, Serum 25-hydroxyvitamin D; CLIA, Chemiluminescent
immunoassay; LC-MS/MS, Liquid chromatography-tandem mass spectrometry; GNHIES98, German National Health Interview and Examination Survey 1998
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Fig. 2 Calibration study results used to standardize serum samples from DEGS1. 25(OH)D, Serum 25-hydroxyvitamin D; CLIA, Chemiluminescent
immunoassay; LC-MS/MS, Liquid chromatography-tandem mass spectrometry; DEGS1, German Health Interview and Examination Survey for Adults
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Fig. 3 Calibration study results used to standardize serum samples from KiGGS. 25(OH)D, Serum 25-hydroxyvitamin D; CLIA, Chemiluminescent
immunoassay; LC-MS/MS, Liquid chromatography-tandem mass spectrometry; KiGGS, German Health Interview and Examination Survey for Children
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Fig. 4 Weighted relative frequency for original and standardized serum 25(OH)D of GNHIES98 samples. 25(OH)D, Serum 25-hydroxyvitamin D;
GNHIES98, German National Health Interview and Examination Survey 1998
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children aged 1 to 2 years, the proportion of serum
25(OH)D< 30 nmol/l was about 5% in both girls and boys
and the proportion of serum 25(OH)D> 50 nmol/l was
about 75% each. In girls aged 11 to 13 years, however, 18.9%
had 25(OH)D levels < 30 nmol/l which was higher than the
11.0% of boys of the same age (Table 5). In return, boys aged
11 to 13 years had higher proportions of serum 25(OH)D
levels > 50 nmol/l than girls of the same age (49.8% vs.
39.6%). In contrast, in the age group 14 to 17 years, girls had
a lower proportion of 25(OH)D levels < 30 nmol/l (13.9%)
than boys of the same age (18.3%), while boys aged 14 to
17 years had lower proportions of serum 25(OH)D levels
> 50 nmol/l than girls of the same age (44.9% vs. 54.2%).
A comparison of the prevalence of vitamin D deficiency,
insufficiency (i.e. serum 25(OH)D > 30 but < 50 nmol/l)
and sufficiency in GNHIES98 and DEGS1 using the stan-
dardized serum 25(OH)D data provides an insight into
temporal changes in vitamin D status in the adult German
population over a decade. The prevalence of vitamin D
deficiency in all adults was very similar in both surveys
(~ 15%), but the prevalence of insufficiency was much
higher in the more recent DEGS1 survey than GNHIES98
(41% vs. 27%, respectively) (Tables 3 and 4). Likewise, the
prevalence of sufficiency was lower in DEGS1 than
GNHIES98 (44% vs. 57%, respectively).
Discussion
The present work highlights how standardization of
25(OH)D data has a substantial impact on estimates of
the vitamin D status in Germany including higher mean
levels, higher prevalence of vitamin D sufficiency and
lower prevalence of vitamin D deficiency overall as well as
in age- and sex-specific analyses. Although the proportion
of persons with deficient 25(OH)D serum levels is
substantially smaller than originally reported, it is still a
considerable number of people within the German popu-
lation. For example, using the prevalences of vitamin D
deficiency based on the new standardized data on serum
25(OH)D < 30 nmol/l from DEGS1 and KiGGS, about
15% of adults and 12.5% of children were vitamin D
deficient which amounts to 11 million persons within the
German population. It is also clear from the standardized
serum 25(OH)D data from GNHIES98 and DEGS1 in the
present work that the prevalence of vitamin D deficiency
has remained stable over a ten year period. However, the
prevalence of insufficiency (30- < 50 nmol/l) was much
Density (Weighted Relative Frequency)
0 100 200 300
0.000
0.005
0.010
0.015
0.020
Stand. 25-Hydroxyvitamin D25-Hydroxyvitamin D 25(OH)D in nmol/l
Fig. 5 Weighted relative frequency for original and standardized serum 25(OH)D of DEGS1 samples. 25(OH)D, Serum 25-hydroxyvitamin D; DEGS1,
German Health Interview and Examination Survey for Adults
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higher in the more recent DEGS1 survey than GNHIES98
(41% vs. 27%, respectively). The present work did not seek
to explore potential underpinning reasons for changes in
vitamin D status over time in the German adult popula-
tion, but this difference may be related to changes in out-
door activity, sun tan behavior or sunscreen use [36].
Within all of the three surveys blood samples were
taken on a voluntary base. We assume that this procedure
did not cause a systematic selection bias, however, also a
weighting factor was used to correct for deviations
compared to the population structure at the time of each
of the surveys. Within GNHIES98, serum 25(OH)D was
measured in a subsample which also participated in a
nutrition module. Participation was randomized; however,
women of child bearing age were oversampled because of
a connected folate study. This deviation in the sample was
corrected by using a specific weighting factor.
The new data on three German national health surveys
complement and extend data from several surveys either
side of the Atlantic that have been standardized according
to VDSP protocols in recent years [16, 17, 19, 23]. Collect-
ively, all of these exercises clearly show that the originally
used assays demonstrate varying precision across the entire
measuring range resulting in minor to major differences
(both positive and negative) between original and standard-
ized serum 25(OH)D data. This was even the case for stud-
ies using the same kind of assay, e.g. CLIA (the original
assay used in the three German surveys), as demonstrated
recently in the data from the ODIN project [23]. For
example, in an Icelandic cohort study including 5519 adults
with mean age of 77 years, the prevalence of serum
25(OH)D level < 30 nmol/l (indicating deficiency) was
lower at 8.4% after standardization compared to the original
estimate of 17.2%. In a population-based survey conducted
in the UK with 977 participants aged > = 19 years,
prevalence of deficiency was about a fifth lower after
standardization (30.7% vs. 24.0%). However, in a Dutch
cohort study including 915 women aged > = 55 years preva-
lence estimates for serum 25(OH)D levels < 30 nmol/l were
slightly higher after standardization (3.8% vs. 4.6%).
Likewise, divergent results in terms of the impact of
standardization have also been reported in surveys for
children and adolescents, which have used the CLIA
[23]. Baseline serum 25(OH)D data from a cross-over
trial conducted in Denmark including 779 children aged
8–11 years, for example, found a higher prevalence of
25(OH)D levels < 30 nmol/l (6.2% compared to 5.0%),
whereas a population-based survey from the UK with
Density (Weighted Relative Frequency)
0 100 200 300
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Fig. 6 Weighted relative frequency for original and standardized serum 25(OH)D of KiGGS samples. 25(OH)D, Serum 25-hydroxyvitamin D; KiGGS,
German Health Interview and Examination Survey for Children and Adolescents
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Table 3 Means and prevalence of 25(OH)D categories based on original and standardized 25(OH)D levels of GNHIES98a
Mean serum 25(OH)D levels Serum 25(OH)D levels by thresholds of the IOM 2011 in %
< 30 nmol/l 30- < 50 nmol/l > = 50 nmol/l
Original Standardized Original Standardized Original Standardized Original Standardized
nmol/l (95% CI) nmol/l (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Women 55.4 (51.8–59.0) 62.0 (58.9–65.1) 23.8 (20.2–27.8) 15.8 (12.8–19.3) 34.0 (30.8–37.3) 28.0 (25.2–30.9) 42.2 (38.3–46.2) 56.3 (52.3–60.2)
18–29 years 65.4 (59.5–71.4) 70.8 (65.7–75.8) 19.5 (14.4–25.9) 18.7 (12.9–26.2) 26.5 (21.8–31.8) 23.7 (18.9–29.3) 54.0 (47.3–60.5) 57.6 (50.3–64.6)
30–39 years 60.3 (55.4–65.2) 66.6 (62.7–70.5) 19.0 (15.2–23.4) 14.4 (10.6–19.4) 32.4 (28.1–37.0) 26.6 (22.2–31.6) 48.6 (47.3–53.7) 58.9 (52.3–65.3)
40–49 years 57.5 (52.8–62.3) 64.4 (60.4–68.4) 21.2 (16.6–26.7) 14.9 (10.5–20.7) 32.5 (27.3–38.2) 30.5 (24.8–36.9) 46.3 (40.5–52.1) 54.6 (46.6–62.4)
50–59 years 52.9 (47.4–58.4) 60.2 (55.4–65.1) 24.2 (18.8–30.5) 17.8 (13.3–23.4) 36.1 (30.5–42.1) 27.4 (22.1–33.4) 39.7 (33.5–46.2) 54.8 (47.5–61.9)
60–69 years 49.3 (44.4–54.2) 56.5 (52.0–61.1) 26.7 (20.1–34.5) 7.3 (4.4–11.8) 40.9 (34.1–48.2) 23.9 (18.3–30.6) 32.4 (26.0–39.5) 68.8 (61.3–75.4)
70–79 years 40.9 (35.0–46.9) 48.2 (42.3–54.1) 37.4 (27.4–48.7) 18.5 (10.7–29.9) 37.7 (28.2–48.3) 31.7 (21.4–44.1) 24.9 (16.3–36.0) 49.9 (37.5–62.3)
Men 53.4 (49.1–57.6) 60.9 (57.1–64.7) 23.6 (19.8–28.0) 15.1 (12.2–18.7) 33.2 (29.9–36.5) 26.9 (23.7–30.5) 43.2 (38.1–48.5) 57.9 (52.7–62.9)
18–29 years 52.2 (47.5–56.8) 60.1 (55.5–64.7) 23.3 (16.9–31.1) 11.9 (8.4–16.7) 31.4 (25.6–37.9) 19.8 (15.5–25.0) 45.3 (38.0–52.8) 68.3 (61.5–74.4)
30–39 years 55.2 (50.0–60.3) 62.3 (57.8–66.9) 22.9 (17.8–28.9) 11.7 (8.7–15.6) 33.4 (28.9–38.3) 27.3 (24.0–31.0) 43.7 (37.8–49.8) 60.9 (56.3–65.4)
40–49 years 51.5 (44.9–58.1) 59.2 (53.2–65.3) 25.4 (19.3–32.5) 13.1 (9.5–17.9) 34.4 (28.0–41.5) 27.7 (23.5–32.3) 40.2 (32.0–49.1) 59.2 (53.8–64.4)
50–59 years 49.4 (44.4–54.4) 57.1 (52.4–61.9) 26.8 (21.4–33.1) 16.0 (11.7–21.4) 34.7 (29.0–40.9) 28.2 (22.7–34.4) 38.5 (31.3–46.2) 55.8 (48.9–62.2)
60–69 years 60.3 (54.2–66.5) 67.7 (62.5–72.8) 15.3 (10.7–21.4) 16.9 (11.7–23.8) 33.9 (27.5–40.9) 33.8 (27.9–40.4) 50.8 (42.9–58.7) 49.2 (42.3–56.1)
70–79 years 51.1 (43.3–58.9) 58.4 (50.8–66.0) 31.3 (21.0–44.0) 30.2 (20.3–42.3) 28.2 (18.3–40.8) 33.0 (24.0–43.5) 40.4 (29.2–52.8) 36.9 (27.0–47.9)
Total 54.4 (50.8–58.0) 61.5 (58.3–64.7) 23.7 (20.3–27.5) 15.5 (12.8–18.6) 33.6 (31.0–36.3) 27.5 (25.1–30.0) 42.7 (38.7–46.8) 57.1 (53.0–61.1)
25(OH)D Serum 25-hydroxyvitamin D, GNHIES98 German National Health Interview and Examination Survey 1998, IOM Institute of Medicine, USA, CI
confidence interval
a Results are weighted population estimates
Table 4 Means and prevalence of 25(OH)D categories based on original and standardized 25(OH)D levels of DEGS1a
Mean serum 25(OH)D levels Serum 25(OH)D levels by thresholds of the IOM 2011 in %
< 30 nmol/l 30- < 50 nmol/l > = 50 nmol/l
Original Standardized Original Standardized Original Standardized Original Standardized
nmol/l (95% CI) nmol/l (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Women 45.9 (43.8–47.9) 49.7 (48.2–51.3) 29.7 (26.5–33.1) 14.7 (12.5–17.2) 31.8 (29.7–33.9) 41.0 (38.5–43.6) 38.6 (35.0–42.3) 44.3 (40.6–48.1)
18–29 years 52.4 (49.2–55.7) 54.2 (51.9–56.5) 25.1 (20.7–30.0) 14.4 (10.7–19.1) 28.4 (24.0–33.3) 34.6 (29.7–39.8) 46.5 (40.8–52.2) 51.0 (45.3–56.7)
30–39 years 48.2 (43.9–52.4) 51.5 (48.3–54.7) 32.2 (26.1–39.0) 18.7 (14.1–24.4) 24.4 (20.1–29.2) 33.0 (28.1–38.3) 43.4 (36.7–50.4) 48.3 (41.3–55.3)
40–49 years 46.1 (43.0–49.2) 50.0 (47.6–52.3) 29.5 (24.4–35.2) 14.8 (11.2–19.2) 30.7 (26.6–35.3) 39.3 (34.7–44.1) 39.8 (34.4–45.4) 45.9 (40.2–51.7)
50–59 years 43.5 (41.2–45.7) 48.1 (46.3–49.8) 30.3 (25.8–35.1) 14.9 (11.6–18.8) 32.5 (28.4–36.9) 42.2 (37.9–46.7) 37.2 (32.1–42.6) 42.9 (37.7–48.3)
60–69 years 43.9 (41.5–46.4) 48.4 (46.5–50.3) 27.2 (22.9–31.9) 9.8 (7.4–12.9) 36.9 (32.2–41.7) 48.5 (43.3–53.7) 36.0 (30.4–41.9) 41.7 (36.2–47.6)
70–79 years 39.8 (37.3–42.2) 45.2 (43.3–47.1) 35.4 (29.4–41.8) 15.9 (12.0–20.7) 39.2 (33.9–44.8) 51.1 (45.2–57.0) 25.5 (20.5–31.2) 33.0 (27.5–39.0)
Men 45.3 (42.8–47.8) 49.3 (47.4–51.2) 30.8 (26.8–35.2) 15.7 (12.9–19.0) 30.9 (28.4–33.6) 40.5 (37.3–43.8) 38.3 (33.8–42.9) 43.7 (39.2–48.4)
18–29 years 46.7 (42.7–50.8) 50.5 (47.4–53.5) 31.6 (26.1–37.6) 16.2 (12.2–21.1) 29.1 (24.6–34.1) 39.7 (34.3–45.4) 39.3 (33.3–45.7) 44.1 (37.9–50.4)
30–39 years 43.4 (39.3–47.5) 48.0 (44.8–51.2) 36.4 (29.5–43.9) 19.0 (14.0–25.2) 28.9 (23.6–35.0) 42.7 (35.4–50.2) 34.7 (27.6–42.4) 38.4 (31.0–46.3)
40–49 years 45.2 (41.7–48.8) 49.0 (46.5–51.6) 33.6 (27.4–40.3) 19.4 (14.4–25.5) 26.6 (21.9–32.0) 36.0 (30.5–41.9) 39.8 (33.6–46.4) 44.6 (38.1–51.4)
50–59 years 44.2 (41.7–46.7) 48.6 (46.7–50.5) 29.5 (24.3–35.2) 13.3 (9.6–18.1) 34.4 (30.0–39.2) 44.9 (40.0–49.9) 36.1 (30.8–41.7) 41.8 (36.5–47.3)
60–69 years 48.0 (45.0–50.9) 51.3 (49.1–53.6) 22.1 (17.2–27.9) 9.9 (7.0–13.8) 33.3 (28.1–38.9) 38.1 (32.8–43.6) 44.6 (38.3–51.2) 52.1 (45.7–58.4)
70–79 years 43.9 (40.9–46.9) 48.3 (46.1–50.6) 29.7 (23.7–36.5) 14.9 (10.5–20.8) 36.3 (30.7–42.3) 43.6 (37.7–49.7) 34.0 (28.1–40.5) 41.5 (34.9–48.4)
Total 45.6 (43.5–47.7) 49.5 (47.9–51.1) 30.2 (26.9–33.8) 15.2 (13.0–17.8) 31.3 (29.4–33.3) 40.8 (38.3–43.3) 38.4 (34.7–42.3) 44.0 (40.2–47.9)
25(OH)D Serum 25-hydroxyvitamin D, DEGS1 German Health Interview and Examination Survey for Adults, IOM Institute of Medicine, USA, CI
confidence interval
a Results are weighted population estimates
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511 children and adolescents aged 1–18 years described
a moderately lower prevalence compared to original
values (18.4% versus 23.3%).
Besides the well-reported between-laboratory differences
even for the same assay [14], these differences may also be
linked to methodological issues even within the CLIA assay
over time e.g. assay drift/shift or changes in assay compos-
ition like reformulation of reagents [37, 38]. It is possible
that the process of standardization of the German data may
have contributed to the observed differences. First, the stor-
age time of re-analyzed blood samples used for VDSP
standardization was relatively long (4–17 years). However,
Table 5 Means and prevalence of 25(OH)D categories based on original and standardized 25(OH)D levels of KiGGSa
Mean serum 25(OH)D levels Serum 25(OH)D levels by thresholds of the IOM 2011 in %
< 30 nmol/l 30- < 50 nmol/l > = 50 nmol/l
Original Standardized Original Standardized Original Standardized Original Standardized
nmol/l (95% CI) nmol/l (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Girls 46.7 (44.1–49.3) 53.2 (51.1–55.3) 27.1 (22.9–31.9) 12.5 (10.0–15.7) 36.8 (34.4–39.2) 33.5 (30.3–36.8) 36.1 (31.8–40.6) 54.0 (48.9–59.0)
1–2 years 62.1 (58.5–65.7) 63.8 (61.3–66.3) 14.2 (10.4–19.0) 5.7 (3.5–9.0) 24.7 (19.6–30.6) 19.7 (15.2–25.2) 61.1 (53.9–67.9) 74.6 (68.5–79.9)
3–6 years 48.8 (45.6–52.0) 55.3 (52.9–57.7) 22.2 (17.7–27.4) 9.1 (6.5–12.6) 38.5 (34.9–42.2) 31.8 (27.6–36.3) 39.4 (33.9–45.1) 59.1 (52.9–65.0)
7–10 years 43.5 (40.8–46.3) 51.4 (49.1–53.7) 28.3 (23.2–34.0) 12.2 (9.2–16.1) 40.2 (36.4–44.2) 36.7 (32.2–41.3) 31.5 (26.4–37.1) 51.1 (44.9–57.3)
11–13 years 37.8 (35.3–40.3) 46.7 (44.4–49.0) 36.2 (30.3–42.5) 18.9 (14.7–24.1) 41.3 (37.1–45.6) 41.4 (37.3–45.7) 22.6 (18.4–27.3) 39.6 (34.0–45.5)
14–17 years 48.0 (44.8–51.1) 53.5 (51.1–56.0) 29.0 (24.1–34.5) 13.9 (10.8–17.6) 34.0 (30.8–37.3) 32.0 (28.4–35.7) 37.0 (32.1–42.2) 54.2 (48.6–59.7)
Boys 47.4 (44.6–50.2) 53.7 (51.5–56.0) 26.9 (22.5–31.7) 12.5 (9.7–15.8) 35.3 (33.1–37.6) 32.7 (29.4–36.2) 37.8 (33.3–42.6) 54.8 (49.4–60.1)
1–2 years 66.2 (62.2–70.2) 66.3 (63.9–68.8) 10.8 (7.8–14.9) 4.9 (2.8–8.2) 23.0 (18.5–28.2) 15.5 (11.6–20.5) 66.2 (59.8–72.0) 79.6 (73.7–84.5)
3–6 years 48.4 (44.9–51.8) 54.6 (51.9–57.3) 26.4 (21.1–32.4) 11.5 (8.4–15.5) 32.6 (29.0–36.3) 31.5 (27.0–36.3) 41.1 (35.2–47.2) 57.0 (50.4–63.5)
7–10 years 46.4 (43.5–49.4) 53.8 (51.4–56.3) 23.8 (19.1–29.2) 10.9 (8.0–14.6) 39.4 (35.9–43.0) 31.6 (27.2–36.3) 36.8 (31.3–42.7) 57.5 (51.1–63.8)
11–13 years 45.0 (41.5–48.5) 52.1 (49.6–54.6) 26.9 (22.1–32.3) 11.0 (7.8–15.3) 41.9 (38.5–45.5) 39.2 (34.1–44.5) 31.2 (26.3–36.5) 49.8 (43.5–56.1)
14–17 years 42.1 (39.1–45.0) 49.4 (47.0–51.9) 35.7 (30.2–41.6) 18.3 (14.4–22.9) 34.3 (30.8–38.0) 36.8 (33.3–40.4) 30.0 (25.5–34.9) 44.9 (39.4–50.7)
Total 47.1 (44.4–49.7) 53.5 (51.3–55.6) 27.0 (22.8–31.7) 12.5 (9.9–15.6) 36.0 (34.0–38.1) 33.1 (30.0–36.3) 37.0 (32.7–41.5) 54.4 (49.3–59.5)
25(OH)D Serum 25-hydroxyvitamin D, KiGGS German Health Interview and Examination Survey for Children and Adolescents, IOM Institute of Medicine,
USA, CI confidence interval
a Results are weighted population estimates
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several studies indicate that serum 25(OH)D is stable even
after long-term storage [39–42]. Moreover, multiple
freeze-thaw cycles also seem to have no considerable conse-
quences on serum 25(OH)D [43, 44]. Second, analyses and
re-analyses were conducted in different laboratories and as
mentioned above, this might have had an effect on differ-
ences seen in original and standardized 25(OH)D data.
Third, only 160–171 bio-banked blood samples were
re-analyzed with LC-MS/MS to develop a calibration equa-
tion to predict 25(OH)D levels for the entire samples of
each survey. However, these 160–171 samples were based
on power calculations and also were derived from a specific
uniform sampling procedure within quartiles which has
been shown in simulations to provide for the most efficient
coverage of the full distribution of the sample in question.
In addition, previous studies showed very good concord-
ance between VDSP protocol predicted 25(OH)D levels
and analyses comprising the entire sample [16].
Challenges in the evaluation and comparison of vitamin
D data may also be caused by the fact that there is cur-
rently no consensus on optimal levels of serum 25(OH)D
[3, 4, 45, 46]. In addition, the most commonly used
thresholds to define vitamin D deficiency, insufficiency
and sufficiency (25(OH)D levels, < 30, 30- < 50 and
> =50 nmol/l, respectively, as suggested by the IOM [3]),
are being used irrespective from the assay employed.
According to the wide range of methodological issues,
the interpretation of the actual vitamin D status is com-
plicated, especially the diagnosis of vitamin D deficiency.
Hence, in clinical settings, the potential misclassification
of 25(OH)D levels may result in over- or undertreatment
of patients and difficulties in monitoring supplementa-
tion therapy.
Furthermore, variable and non-comparable 25(OH)D
levels also impede epidemiological research, e.g. the devel-
opment and establishment of evidence-based reference
values for the evaluation of vitamin D status, especially
deficiency and sufficiency, is challenging [45].
For instance, data sources which have been used to
derive reference values for Vitamin D deficiency are also
largely based on unstandardized 25(OH)D measure-
ments. The consequences of this are not totally clear
and this derivation process should be revised [45]. More-
over, valid quantification of vitamin D deficiency in (na-
tionally representative) populations is required to develop
dietary reference values as well as to evaluate the need for
evidence-based public health strategies e.g. food fortifica-
tion [16, 23].
Table 6 Predicted data shifts from original to standardized 25(OH)D levels for GNHIES98, DEGS1 and KiGGS
GNHIES98 DEGS1 KiGGS
Serum 25(OH)D levels in nmol/l Serum 25(OH)D levels in nmol/l Serum 25(OH)D levels in nmol/l
Original Standardized Original Standardized Original Standardized
1 1 1 15 1 10
5 6 5 18 5 15
10 12 10 22 10 20
15 18 15 26 15 25
20 24 20 30 20 30
25 30 25 34 25 35
30 36 30 38 30 40
40 49 40 45 40 50
50 61 50 53 50 61
60 73 60 61 60 71
75 91 75 72 75 76
80 93 80 76 80 77
90 98 90 84 90 80
100 104 100 92 100 84
125 117 125 109 125 91
150 131 150 110 150 99
200 159 200 113 200 115
250 186 250 115 250 130
300 213 300 118 300 146
25(OH)D Serum 25-hydroxyvitamin D, GNHIES98 German National Health Interview and Examination Survey 1998, DEGS1 German Health Interview and
Examination Survey for Adults, KiGGS German Health Interview and Examination Survey for Children and Adolescents
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The current results show that, depending on the labora-
tory method, the estimation of population quantities at risk
of deficiency and insufficiency may differ substantially
which should be considered while implementing prevention
measures. Accurate quantification of the magnitude of the
public health problem is a critical piece of data upon which
national health policy relies. It has been suggested that from
a public health perspective, a prevalence of micronutrient
deficiency at a rate greater than 20% in the entire popula-
tion and/or in subsets of the population considered espe-
cially at risk (e.g., infants, children and pregnant women)
constitutes a public health issue that may warrant interven-
tion [47]. This is of consequence in the present work where
the estimate of vitamin D deficiency was > 20% in all three
German surveys before standardization, but all fell below
20% following standardization.
However, a previous publication of the ODIN (Food--
based solutions for optimal vitamin D nutrition and health
through the life cycle) project included sensitivity analyses
on the impact of the standardization on estimates of the
association between vitamin D and all-cause mortality as a
major adverse outcome measure [48]. For the mortality
risk estimates of pooled data analyses that included data
from our surveys, the work reported that no major
differences between original and standardized 25(OH)D
concentrations were observed, but a few percent of the
participants, which is relevant from a public health per-
spective, were indeed re-classified into different 25(OH)D
groups after the standardization procedure. Estimates for
the DEGS1 data in particular became slightly lower after
standardization but did not differ significantly from results
using original data. In general, the standardization had an
important impact on classification of subgroups, but it has
not a large impact on individual risk estimation.
Conclusions
The use of standardization of 25(OH)D levels has a
substantial impact on estimates of the vitamin D status in
Germany. Clinical diagnostic and therapeutic as well as
public health decision-making require valid and compar-
able data. Therefore, standardization and calibration of
commercial, clinical and research laboratory assays for
25(OH)D measurement should become common practice.
Although the VDSP made substantial progress to over-
come the mentioned problems in the past few years, there
is still some way to go. Until then, laboratory technicians,
physicians, researchers, and authorities must be aware of
limitations when comparing and interpreting vitamin D
values especially those derived from different assays and
laboratories.
Disclaimer: The findings and conclusions in this report
are those of the authors and do not necessarily represent
the views of the National Institutes of Health or the US
Department of Health and Human Services.
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